Unique dietary-related mouse model of colitis

Inflammatory Bowel Diseases

Volumn 12, Issue 4, 2006, Pages 278-293

  Bernstein, Harris ^a,b   Holubec, Hana ^a   Bernstein, Carol ^a,d   Ignatenko, Natalia ^a,b   Gerner, Eugene ^a,b   Dvorak, Katerina ^a,b,d   Besselsen, David ^c   Ramsey, Lois ^d   Dall'Agnol, Monique ^a   Blohm Mangone, Karen Ann ^b   Padilla Torres, Jose ^b   Cui, Haiyan ^a,b   Garewal, Harinder ^a,b,d   Payne, Claire Margaret ^a,b,d  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

Angiogenesis; Bile acids; Colitis; Deoxycholate; IBD; Inflammation

Indexed keywords

BILE ACID; COMPLEMENTARY DNA; DEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLITIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DNA DAMAGE; DNA MICROARRAY; DNA REPAIR; EPITHELIUM CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIFESTYLE; LIPID DIET; MOUSE; NITROSATION; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; WILD TYPE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; COLITIS; DIETARY FATS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA; FOLLOW-UP STUDIES; GENE EXPRESSION; INTESTINAL MUCOSA; MICE; OXIDATIVE STRESS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 33646787819     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000209789.14114.63     Document Type: Article

References (95)

1. Shoda R, Matsueda K, Yamato S, et al. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996;63:741-745.
2. Reif S, Klein I, Lubin F, et al. Pre-illness dietary factors in inflammatory bowel disease. Gut. 1997;40(6):754-760.
3. Geerling BJ, Dagnelie PC, Badart-Smook A, et al. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol. 2000;95:1008-1013.
4. Sakamoto N, Kono S, Wakai K, et al. Dietary risk factors for inflammatory bowel diesease. A multicenter case-control study in Japan. Inflamm Bowel Dis. 2005;11:154-163.
5. Reddy BS. Diet and excretion of bile acids. Cancer Res. 1981;41:3766-3768.
6. Bernstein H, Bernstein C, Payne CM, et al. Bile acids as carcinogens in human gastrointestinal cancers. Rev Mutat Res. 2005;589:47-65.
7. Jurjus AR, Khoury NN, Reimund JM. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods. 2004;50:81-92.
8. Bernstein H, Payne CM, Bernstein C, et al. Activation of the promoters of genes associated with DNA damage, oxidative stress, ER stress and protein malfolding by the bile salt, deoxycholate. Toxicol Lett. 1999;108:37-46.
9. Payne CM, Crowley C, Washo-Stultz D, et al. The stress-response proteins poly(ADP-ribose) polymerase and NF-κB protect against bile salt-induced apoptosis. Cell Death Different. 1998;5:623-636.
10. Garewal H, Ramsey L, Fass R, et al. Perils of immunohistochemistry: variability in staining specificity of commercially available COX-2 antibodies on human colon tissue. Digest Dis Sci. 2003;48:197-202.
11. Holubec H, Payne CM, Bernstein H, et al. Assessment of apoptosis by immunohistochemical markers compared to cellular morphology in ex vivo-stressed colonic mucosa. J Histochem Cytochem. 2005;53:229-235.
12. Watts GS, Futscher BW, Isett R, et al. cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. J Pharmacol Exp Ther. 2001;299:434-441.
13. Crowley-Weber CL, Payne CM, Gleason-Guzman M. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis. 2002;23:2063-2080.
14. Higgins LM, Frankel G, Douce G, et al. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infection Immunity. 1999;67:3031-3039.
15. Payne CM, Hicks MJ, Kim A. Ultrastructural morphometric analysis of normal human lymphocytes stimulated in vitro with mitogens and antigens. Am J Pathol. 1985;120:263-275.
16. Dardick I. Ultrastructural morphometry and the control of lymphocyte nuclear size in non-Hodgkin lymphoma: a review. Ultrastruct Pathol. 1992;16:137-146.
17. Sato S, Burgess SB, McIlwain DL. Transcription and motoneuron size. J Neurochem. 1994;63:1609-1615.
18. Dijkstra G, Moshage H, Van Dullemen HM, et al. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol. 1998;186:416-421.
19. Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology. 2004;113:427-437.
20. Dedon PC, Tannenbaum SR. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys. 2004;423:12-22.
21. Fukushima K, Yonezawa H, Fiocchi C. Inflammatory bowel disease-associated gene expression in intestinal epithelial cells by differential cDNA screening and mRNA display. Inflamm Bowel Dis. 2003;9:290-301.
22. Hausmann M, Spottl T, Andus T, et al. Subtractive screening reveals up-regulation of NADPH oxidase expression in Crohn's disease intestinal macrophages. Clin Exp Immunol. 2001;125:48-55.
23. Uthoff SM, Eichenberger MR, Lewis RK, et al. Identification of candidate genes in ulcerative colitis and Crohn's disease using cDNA array technology. Int J Oncol. 2001;19:803-810.
24. Mannick EE, Bonomolo JC, Horswell R, et al. Gene expression in mononuclear cells from patients with inflammatory bowel disease. Clin Immunol. 2004;112:247-257.
25. Dieckgraefe BK, Stenson WF, Korzenik JR, et al. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genom. 2000;4:1-11.
26. Mo YY, Yu Y, Theodosiou E, et al. A role for Ubc9 in tumorigenesis. Oncogene. 2005;24:2677-2683.
27. Heikius B, Niemela O, Niemela S, et al. Elevated serum PIIINP and laminin in inflammatory bowel disease indicate hepatobiliary and pancreatic dysfunction. Hepatogastroenterology. 2002;49:404-411.
28. Koutroubakis IE, Petinaki E, Dimoulios P, et al. Serum laminin and collagen IV in inflammatory bowel disease. J Clin Pathol. 2003;56:885-887.
29. Zen K, Babbin BA, Liu Y, et al. JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration. Mol Biol Cell. 2004;15:3926-3937.
30. Kucharzik T, Walsh SV, Chen J, et al. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol. 2001;159:2001-2009.
31. Magdolen U, Schroeck F, Creutzburg S, et al. Non-muscle α-actinin-4 interacts with plasminogen activator inhibitor type-1 (PAE-1). Biol Chem. 2004;385:801-808.
32. Jiang Z, Johnson HJ, Nie H, et al. Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J Biol Chem. 2003;278:10952-10956.
33. Qiu FH, Devchand PR, Wada K, et al. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils. FASEB J. 2001;15:2736-2738.
34. Cui X, Rouhani FN, Hawari F, et al. Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1shedding. J Immunol. 2003;171:6814-6819.
35. Conner EM, Brand S, Davis JM, et al. Proteasome inhibition attenuates nitric oxide synthase expression, VCAM-1 transcription and the development of chronic colitis. J Pharmacol Exp Ther. 1997;282:1615-1622.
36. Yang JH, Nie Y, Zhao Q, et al. Intracellular localization of differentially regulated RNA-specific adenosine deaminase isoforms in inflammation. J Biol Chem. 2003;278:45833-45842.
37. Chang X, Yamada R, Sawada T, et al. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis. Rheumatology (Oxford). 2005;44:293-298.
38. 2+-dependent phospholipase A2. Am J Physiol Heart Circ Physiol. 2005;288:H2306-H2316.
39. Kim I, Moon SO, Koh KN, et al. Molecular coloning, expression, and characterization of angiopoietin-related protein. J Biol Chem. 1999;274:26523-26528.
40. Neid M, Datta K, Stephan S, et al. Role of insulin receptor substrates and protein kinase C-zeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells. J Biol Chem. 2004;279:3941-3948.
41. Joo JH, Alpatov R, Munguba GC, et al. Reduction of Pnn by RNAi induces loss of cell-cell adhesion between human corneal epithelial cells. Mol Vis. 2005;11:133-142.
42. Whittaker CA, Desimone DW. Molecular cloning and developmental expression of the Xenopus homolog of integrin alpha 4. Ann N Y Acad Sci. 1998;23:56-73.
43. Nordman T, Xia L, Bjorkhem-Bergman L, et al. Regeneration of the antioxidant ubiquinol by lipoamide dehydrogenase, thioredoxin reductase and glutathione reductase. Biofactors. 2003;18:45-50.
44. Maeng O, Kim YC, Shin HJ, et al. Cytosolic NADP(+)-dependent isocitrate dehydrogenase protects macrophages from LPS-induced nitric oxide and reactive oxygen species. Biochem Biophys Res Commun. 2004;317:558-564.
45. Masutani H, Ueda S, Yodoi J. The thioredoxin system in retroviral infection and apoptosis. Cell Death Diff. 2005;12:991-998.
46. 2 stress. J Invest Dermatol. 2004;122:307-313.
47. Sun F, Hamagawa E, Tsutsui C, et al. Evaluation of oxidative stress during apoptosis and necrosis caused by D-galactosamine in rat liver. Biochem Pharmacol. 2003;65:101-107.
48. Raab RM, Bullen J, Kelleher J, et al. Regulation of mouse hepatic genes in response to diet induced obesity, insulin resistance and fasting induced weight reduction. Nutr Metab (Lond). 2005;2:15 [Epub ahead of print].
49. Narita T, Nishimura T, Yoshizaki K, et al. CIN85 associates with TNF receptor 1 via Src and modulates TNF-alpha-induced apoptosis. Exp Cell Res. 2005;304:256-264.
50. Divireddy LR, Green MR. Transcriptional program of apoptosis induction following interleukin 2 deprivation: identification of RC3, a calcium/calmodulin binding protein, as a novel proapoptotic factor. Mol Cell Biol. 2003;23:4532-4541.
51. Fleischer A, Ayllon V, Rebollo A. ITM2Bs regulates apoptosis by inducing loss of mitochondrial membrane potential. Eur J Immunol. 2002;32:3498-34505.
52. van Tiel CM, Schenning M, Snoek GT, et al. Overexpression of phosphatidylinositol transfer protein beta in NIH3T3 cells has a stimulatory effect on sphingomyelin synthesis and apoptosis. Biochim Biophys Acta. 2004;163:151-158.
53. Reiss U, Oskouian B, Zhou J, et al. Sphingosine-phospate lyase enhances stress-induced ceramide generation and apoptosis. J Biol Chem. 2004;279:1281-1290.
54. Battisti C, Formichi P, Tripodi SA, et al. Lymphoblastoid cell lines of Rett syndrome patients exposed to oxidative-stress-induced apoptosis. Brain Dev. 2004;26:384-388.
55. Notarnicola M, Messa C, Cavallini A, et al. Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis. Oncology. 2004;67:351-358.
56. Li AL, Li HY, Jin BF, et al. A novel eIF5A complex functions as a regulator of p53 and p53-dependent apoptosis. J Biol Chem. 2004;279:49251-49258.
57. Heyninck K, Van Huffel S, Kreike M, et al. Yeast two-hybrid screening for proteins interacting with the anti-apoptotic protein A20. Methods Mol Biol. 2004;282:223-241.
58. Harada H, Andersen JS, Mann M, et al. P70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci U S A. 2001;98:9666-9670.
59. Jinawath N, Furukawa Y, Nakamura Y. Identification of NOL8, a nucleolar protein containing an RNA recognition motif (RRM), which was overexpressed in diffuse-type gastric cancer. Cancer Sci. 2004;95:430-435.
60. Jin S, Zhuo Y, Guo W, et al. PAK1-dependent phosphorylation of RAF-1 regulates its mitochondrial localization, phosphorylation of BAD, and BCL-2 association. J Biol Chem. 2005;280:24698-24705.
61. Rotter B, Kroviarski Y, Nicolas G, et al. αII-Spectrin is an in vitro target for caspase-2, and its cleavage is regulated by calmodulin binding. Biochem J. 2004;378:161-168.
62. Jamieson L, Carpenter L, Biden TJ, et al. Protein kinase C iota activity is necessary for Bcr-Abl-mediated resistance to drug-induced apoptosis. J Biol Chem. 1999;274:3927-3930.
63. Gronroos E, Terentiev AA, Punga T, et al. YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress. Proc Natl Acad Sci U S A. 2004;101:12165-12170.
64. Sharma MR, Tuszynski GP, Sharma MC. Angiostatin-induced inhibition of endothelial cell proliferation/apoptosis is associated with the down-regulation of cell cycle regulatory protein cdk5. J Cell Biochem. 2004;91:398-409.
65. Okuda Y, Nishi R, Ng JMY, et al. Relative levels of the two mammalian Rad23 homologs determine composition and stability of the Xeroderma pigmentosum group C protein complex. DNA Repair. 2004;3:1285-1295.
66. Wagner KU, Drempler A, Qi Y, et al. Tsg101 is essential for cell growth, proliferation, and cell survival of embryonic and adult tissues. Mol Cell Biol. 2003;23:150-162.
67. Butz N, Ruetz S, Natt F, et al. The human ubiquitin-conjugating enzyme Cdc34 controls cellular proliferation through regulation of p27Kip1 protein levels. Exp Cell Res. 2005;15:482-493.
68. Yuan H, Kamata M, Xie YM, et al. Increased levels of Wee-1 kinase in G(2) are necessary for Vpr- and gamma irradiation-induced G(2) arrest. J Virol. 2004;78:8183-8190.
69. - exchanger in gastric surface mucous and duodenal villus cells. Am J Physiol Gastrointest Liver Physiol. 2003;285:G1225-G1234.
70. Malik B, Yue Q, Yue G, et al. Role of Nedd4-2 and polyubiquitination in epithelial sodium channel degradation in untransfected renal A6 cells expressing endogenous EnaC subunits. Am J Physiol Renal Physiol. 2005;289:F107-F116.
71. + channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavernosum. Naunyn Schmiedebergs Arch Pharmacol. 2004;369:602-615.
72. Collins JF, Bai L, Ghishan FK. The SLC20 family of proteins: dual functions as sodium-phosphate cotransporters and viral receptors. Pflugers Arch. 2004;447:647-652.
73. Angelats C, Wang XW, Jermiin LS, et al. Isolation and characterization of the mouse ubiquitin-specific protease Usp15. Mamm Genome. 2003;14:31-46.
74. Mizushima N, Yoshimori T, Ohsumi Y. Role of the Apg12 conjugation system in mammalian autophagy. Int J Biochem Cell Biol. 2003;35:553-561.
75. Alberts DS, Einspahr JG, Earnest DL, et al. Fecal bile acid concentrations in a sub-population of the wheat bran fiber colon polyp trial. Cancer Epidemiol Biomark Prevent. 2003;12:197-2000.
76. Eyssen HJ, DePauw G, Van Eldere J. Formation of hyodeoxycholic acid from muricholic acid and hyocholic acid by an unidentified gram-positive rod termed HDCA-1 isolated from rat intestinal microflora. Appl Environ Microbiol. 1999;65:3158-3163.
77. Washo-Stultz CL, Crowley-Weber D, Dvorakova K, et al. Role of mitochondrial complexes I and II, reactive oxygen species and arachidonic acid metabolism in deoxycholate-induced apoptosis. Cancer Lett. 2002;177:129-144.
78. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-429.
79. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002;122:44-54.
80. Taurog JD, Richardson JA, Croft JT, et al. The germ-free state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994;180:2359-2364.
81. Girardin SE, Hugot JP, Sansonetti PJ. Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing. Trends Immunol. 2003;24:652-658.
82. Elson CO, Cong Y, Iqbal N, et al. Immuno-bacterial homeostasis in the gut: new insights into an old enigma. Semin Immunol. 2001;13:187-194.
83. Rath HC, Herfarth HH, Ikeda JS, et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest. 1996;98:945-953.
84. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998;66:5224-5231.
85. Onderdonk AB. Intestinal microflora and inflammatory bowel disease. In: Kirsner JB, ed. Inflammatory Bowel Disease, 5th ed. Philadelphia: W.B. Saunders; 2000:144-152.
86. Cohavy O, Bruckner D, Gordon LK, et al. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun. 2000;68:1542-1548.
87. Duchmann R, Kaiser I, Hermann E, et al. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol. 1995;102:448-455.
88. Landers CJ, Cohavy O, Misra R, et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002;123:689-699.
89. Floch MH. Bile salts, intestinal microflora and enterohepatic circulation. Dig Liv Dis. 2002;34:554-557.
90. Magnuson BA, Shirtliff N, Bird RP. Resistance of aberrant crypt foci to apoptosis induced by azoxymethane in rats chronically fed cholic acid. Carcinogenesis. 1994;15:1459-1462.
91. Radtke F, Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science. 2005;307:1904-1909.
92. Crowley-Weber CL, Dvorakova K, Crowley C, et al. Nicotine increases oxidative stress, activates NF-kappaB and GRP78, induces apoptosis and sensitizes cells to genotoxic/xenobiotic stresses by a multiple stress inducer, deoxycholate: relevance to colon carcinogenesis. Chem-Biol Interact. 2003;145:53-66.
93. Zong H, Ren JM, Young LH, et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc Natl Acad Sci U S A. 2002;99:15983-15987.
94. Batta AK, Salen G, Holubec H, et al. Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-insoluble fraction after feeding to rats with colon polyps. Cancer Res. 1998;58:1684-1687.
95. Pardi DS, Loftus EV, Kremers WK, et al. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology. 2003;124:889-893.